Theratechnologies Inc. Form 6-K Filing: Key Insights & Compliance Update

Here are the key insights extracted from the provided section of the financial report:
- Filing Type: The document is a Form 6-K, which is typically used by foreign private issuers to report significant events or information to the SEC.
- Company Information:
- Name: Theratechnologies Inc.
- Address: 2015 Peel Street, Suite 1100, Montréal, Québec, Canada, H3A 1T8.
- Filing Date: The report was submitted on February 14, 2025.
- Commission File Number: 001-35203, which identifies the company in SEC records.
- Purpose of Filing:
- The registrant indicates whether it will file annual reports under Form 20-F or Form 40-F.
- The document also includes checkboxes for submissions in paper form and compliance with Regulation S-T, although no specific responses are provided in the extracted text.
- Signature Section:
- The report is signed by Jocelyn Lafond, who is the General Counsel and Corporate Secretary, indicating that the report is duly authorized and legally compliant.
- Exhibits: The report references a press release dated February 13, 2025, which may contain additional significant information.
- Regulatory Compliance: The document notes compliance with various SEC regulations, which is crucial for ensuring that the information is officially recognized and meets legal obligations.
This summary highlights the essential components of the report, including company identification, filing details, compliance, and key personnel involved in the filing process.